January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. ... today announces the close of its $50M Series B financing, bringing the total raised to date to over $90 million.

prnewswire.com

January 17, 2024 - Ratio Therapeutics

6 days from now

January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical Company …

ratiotx.com

News - Ratio Therapeutics

6 days from now

January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical Company …

ratiotx.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. PR Newswire . Wed, Jan 17, 2024, 8:00 AM 3 min read. In This Article: BMY .

yahoo.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

biospace.com

Ratio Therapeutics Raises $50M For Tumor-targeting …

6 days from now

Jan 17, 2024. Listen to this ... Ratio Therapeutics Inc. has secured the backing to move its first drug candidate into clinical trials by the end of this year. ... Ratio announced its $50M Series ...

bizjournals.com

Ratio Therapeutics Secures $50M Series B To Develop Cancer …

6 days from now

Jan 18, 2024  · Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments. ... The company hopes to move this candidate into clinical trials by the end of 2024. This article was …

builtinboston.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment PR Newswire BOSTON, Jan. 17, 2024 Boston-Based...

marketwatch.com

Ratio Therapeutics Raises $50M In Series B Financing

6 days from now

Jan 17, 2024  · Ratio Therapeutics Raises $50M in Series B Financing Jan 17, 2024 ... Save for later NEW YORK – Ratio Therapeutics on Wednesday announced that it has raised $50 …

precisionmedicineonline.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

Jan 17, 2024  · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, MA, USA I January 17, 2024 I Ratio …

pipelinereview.com

Ratio Therapeutics Raises $50M In Series B Financing - FinSMEs

6 days from now

By FinSMEs. -. January 19, 2024. Ratio Therapeutics, a Boston, MA-based pharmaceutical company, raised $50M in Series B funding. The round, which brought the total amount to …

finsmes.com

Ratio Therapeutics Secures Funds For Cancer Radiotherapies

6 days from now

Jan 18, 2024  · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …

pharmaceutical-technology.com

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

6 days from now

Jan 17, 2024  · Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted …

crunchbase.com

2024 - Ratio Therapeutics

6 days from now

Jun 20, 2024  · January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment. Boston-Based Radiopharmaceutical …

ratiotx.com

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

On January 17, 2024 Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the …

1stoncology.com

Media - Ratio Therapeutics

6 days from now

Oct 23, 2024  · Boston’s Ratio Therapeutics Raises $50M Series B For R&D. Law360 | January 17th, 2024. Pharmaceutical startup Ratio Therapeutics has raised a fresh round of funding, the …

ratiotx.com

Ratio Raises $50M As Radiopharma Field Finds Its Groove

6 days from now

Jan 17, 2024  · Radiopharmaceutical biotech Ratio Therapeutics has raised a $50 million Series B to bring its first therapeutic into the clinic, it said Wednesday morning. ... January 17, 2024 …

endpts.com

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, January 17, 2024-- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for …

vcaonline.com

Ratio Therapeutics Closes $50M Series B Financing - Citybiz

6 days from now

January 17, 2024 Ratio Therapeutics Inc. , a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and …

citybiz.co

Novartis Strengthens Radiopharma Leadership With Ratio …

6 days from now

3 days ago  · Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance radiopharmaceutical therapies.

yahoo.com